Deep dive into muscle repair yields new strategies to combat Duchenne muscular dystrophy

4.6 (269) · $ 6.99 · In stock

Researchers at the Sanford Burnham Prebys Medical Discovery Institute (SBP) reported new findings this week that may lead to novel therapeutic strategies for people suffering from Duchenne muscular dystrophy (DMD). DMD, a muscle-wasting disease that affects 1 in 7250 males aged 5 to 24 years in the United States, is caused by a genetic mutation leading…

Frontiers Duchenne muscular dystrophy: disease mechanism and therapeutic strategies

Current Strategies of Muscular Dystrophy Therapeutics: An Overview

Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future

muscle stem cells, The Stem Cellar

Promising disease modifying approach to Duchenne muscular

Frontiers Emerging gene editing strategies for Duchenne muscular dystrophy targeting stem cells

Duchenne Muscular Dystrophy Therapeutics Market Outlook, Size, Prominent Players, Share, Challenges and Forecast 2028

Regenerative Rehabilitation for Duchenne Muscular Dystrophy

Sanford Burnham Prebys Medical Discovery Institute

Frontiers Current Pharmacological Strategies for Duchenne Muscular Dystrophy